In vitro/in vivo effects of some new 2,5-disubstituted 1,3,4-oxadiazole and hydrazone analogues targeting Parkinson's disease

Karabelyov, Valentin; Angelova, Violina T.; Sharkov, Martin; Mihaylova, Rositsa; Popov, Georgi; Pencheva, Tania; Manov, Vasil; Dangalov, Miroslav; Todorova, Nadezhda; Kondeva-Burdina, Magdalena

doi:10.1016/j.molstruc.2023.135755

Journal of Molecular Structure

2023

DOI: 10.1016/j.molstruc.2023.135755

|View full text |Cite

In vitro/in vivo effects of some new 2,5-disubstituted 1,3,4-oxadiazole and hydrazone analogues targeting Parkinson's disease

Valentin Karabelyov,

Violina T. Angelova,

Martin Sharkov

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Novel Aromatic Heterocycles for Dual MAO A and B Inhibitors: A Promising Strategy for Parkinson's Disease Treatment

Swati,

Raza,

Singh

et al. 2025

ChemistrySelect

View full text Add to dashboard Cite

Recent advancements in the synthesis of aromatic heterocycles have shown promise in the inhibition of monoamine oxidase (MAO) A and B enzymes implicated in the pathophysiology of Parkinson's disease (PD). These heterocyclic compounds are of particular interest due to their structural diversity and significant pharmacological potential.This review discusses various strategies for enhancing MAO inhibitory activity, emphasizing positional modifications. Notable progress includes the development of thiazole‐based and imidazole‐based heterocycles with detailed exploration of their synthetic methodologies and structure–activity relationships. These compounds have demonstrated potential in targeting the metabolism of neurotransmitters, particularly dopamine, which is crucial for managing PD symptoms.The synthesis of aromatic heterocycles targeting MAO A and B inhibition offers a promising pathway for developing novel therapeutics for Parkinson's disease. The structural diversity and pharmacological potential of these compounds, combined with their ability to modulate neurotransmitter levels, present a hopeful avenue for more effective PD management. However, further research, including structure‐based design and in vivo validation, is essential to fully realize their therapeutic efficacy and improve treatment outcomes for Parkinson's disease.

show abstract

Novel Aromatic Heterocycles for Dual MAO A and B Inhibitors: A Promising Strategy for Parkinson's Disease Treatment

Swati,

Raza,

Singh

et al. 2025

ChemistrySelect

View full text Add to dashboard Cite

show abstract

Safety assessment of novel oxadiazole derivatives in acute and sub-acute toxicity studies

Zainab,

Khan,

Nadeem

et al. 2024

Naunyn-Schmiedeberg's Arch Pharmacol

View full text Add to dashboard Cite

Synthesis of novel 1,2,3-triazole-tethered N-acyl hydrazones as a new class of carbonic anhydrase II inhibitors: In vitro and in silico potentials

Fatima,

Saeed,

Ullah

et al. 2024

Bioorganic Chemistry

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

In vitro/in vivo effects of some new 2,5-disubstituted 1,3,4-oxadiazole and hydrazone analogues targeting Parkinson's disease

Cited by 3 publications

References 45 publications

Novel Aromatic Heterocycles for Dual MAO A and B Inhibitors: A Promising Strategy for Parkinson's Disease Treatment

Novel Aromatic Heterocycles for Dual MAO A and B Inhibitors: A Promising Strategy for Parkinson's Disease Treatment

Safety assessment of novel oxadiazole derivatives in acute and sub-acute toxicity studies

Synthesis of novel 1,2,3-triazole-tethered N-acyl hydrazones as a new class of carbonic anhydrase II inhibitors: In vitro and in silico potentials

Contact Info

Product

Resources

About